4.6 Article

Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis

Journal

SURGERY
Volume 148, Issue 2, Pages 354-363

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.surg.2010.05.011

Keywords

-

Categories

Funding

  1. National Cancer Institute [R01 CA93999, T32CA106183]
  2. GI SPORE [CA95103]

Ask authors/readers for more resources

Background. Gastric adenocarcinoma is a leading cause of cancer mortality. The role of dopamine and cAMP regulated phosphoprotein MW 32 kDa (DARPP-32) overexpression in the gastric tumor genesis cascade remains unclear Methods. The expression of DARP-32 in the multistep caranogenesis cascade was examined using immunohistochemistry analysis on 533 samples The contribution of DARPP-32 in cellular transformation and molecular signaling was investigated using NIH3T3, AGS, and SNU16 cells Results. The composite expression score (CES), calculated from immunostaining patterns, increased ignificantly from normal or gastritis to metaplasia, dysplasia, and adenocarcinoma (P < 001). In patients with normal stomach or gastritis and tumor samples, a 76% and 77% chance, respectively, was found (P < 001) that CES was higher in the tumor High median CES correlated with well- or moderately differentiated (P = .03) gastric adenocarcinomas. NIH3T3 cells transfected with DARPP-32 demonstrated increased levels of phospho-AKT and a 5-fold increase in the number of foci as compared ith the control (P =.02). DARPP-32 expression in AGS cells led to increased protein levels of phospho-AKT and BCL-2. For validation, the knockdown of endogenous DARPP-32 expression in,SNU16 cells using shRNA resulted in decreased levels of phospho-AKT phosphorylation and BCL-2 Conclusion. Our results suggest that DARPP-32 overexpression may participate in the transition to intestinal metaplasza and in the progression to neoplasia The ability of DARP-32 to transform NIH3T3 cells and to regulate AKT and BCL-2 underscores its possible oncogenic potential (Singer), 2010,148:354-63.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Bone health in long-term gastric cancer survivors: A prospective study of high-dose vitamin D supplementation using an easy administration scheme

Marta Climent, Manuel Pera, Isabel Aymar, Jose M. Ramon, Luis Grande, Xavier Nogues

JOURNAL OF BONE AND MINERAL METABOLISM (2018)

Article Oncology

International consensus on a complications list after gastrectomy for cancer

Gian Luca Baiocchi, Simone Giacopuzzi, Daniele Marrelli, Daniel Reim, Guillaume Piessen, Paulo Matos da Costa, John V. Reynolds, Hans-Joachim Meyer, Paolo Morgagni, Ines Gockel, Lucio Lara Santos, Lone Susanne Jensen, Thomas Murphy, Shaun R. Preston, Mikhail Ter-Ovanesov, Uberto Fumagalli Romario, Maurizio Degiuli, Wojciech Kielan, Stefan Moenig, Piotr Kolodziejczyk, Wojciech Polkowski, Richard Hardwick, Manuel Pera, Jan Johansson, Paul M. Schneider, Wobbe O. de Steur, Suzanne S. Gisbertz, Henk Hartgrink, Joanna W. van Sandick, Nazario Portolani, Arnulf H. Hoelscher, Maristella Botticini, Franco Roviello, Christophe Mariette, William Allum, Giovanni De Manzoni

GASTRIC CANCER (2019)

Article Surgery

Perioperative transfusion management in gastric cancer surgery: Analysis of the Spanish subset of the EURECCA oesophago-gastric cancer registry

Javier Osorio, Carlos Jerico, Coro Miranda, Elisenda Garsot, Alexis Luna, Monica Miro, Maite Santamaria, Eva Artigau, Joaquin Rodriguez-Santiago, Sandra Castro, Josep Feliu, Aurora Aldeano, Caries Olona, Dulce Momblan, David Ruiz, Gonzalo Galofre, Inmaculada Pros, Xabier Garcia-Albeniz, Miguel Lozano, Manuel Pera

CIRUGIA ESPANOLA (2018)

Article Surgery

Benchmarking Complications Associated With Esophagectomy

Donald E. Low, Madhan Kumar Kuppusamy, Derek Alderson, Ivan Cecconello, Andrew C. Chang, Gail Darling, Andrew Davies, Xavier Benoit D'Journo, Suzanne S. Gisbertz, S. Michael Griffin, Richard Hardwick, Arnulf Hoelscher, Wayne Hofstetter, Blair Jobe, Yuko Kitagawa, Simon Law, Christophe Mariette, Nick Maynard, Christopher R. Morse, Philippe Nafteux, Manuel Pera, C. S. Pramesh, Sonia Puig, John V. Reynolds, Wolfgang Schroeder, Mark Smithers, B. P. L. Wijnhoven

ANNALS OF SURGERY (2019)

Article Surgery

Standardizing the treatment of oesophagogastric junction tumours: Centralization, registries and surgical training

Javier Osorio, Joaquin Rodriguez-Santiago, Josep Roig, Manuel Pera

CIRUGIA ESPANOLA (2019)

Letter Gastroenterology & Hepatology

Patient Blood Management strategies for iron deficiency anemia management in gastric cancer

Carlos Jerico, Javier Osorio, Jose A. Garcia-Erce, Manuel Pera

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Oncology

Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study

Eliza R. C. Hagens, Mark I. van Berge Henegouwen, Johanna W. van Sandick, Miguel A. Cuesta, Donald L. van der Peet, Joos Heisterkamp, Grard A. P. Nieuwenhuijzen, Camiel Rosman, Joris J. G. Scheepers, Meindert N. Sosef, Richard van Hillegersberg, Sjoerd M. Lagarde, Magnus Nilsson, Jari Rasanen, Philippe Nafteux, Piet Pattyn, Arnulf H. Hoelscher, Wolfgang Schroeder, Paul M. Schneider, Christophe Mariette, Carlo Castoro, Luigi Bonavina, Riccardo Rosati, Giovanni de Manzoni, Sandro Mattioli, Josep Roig Garcia, Manuel Pera, Michael Griffin, Paul Wilkerson, M. Asif Chaudry, Bruno Sgromo, Olga Tucker, Edward Cheong, Krishna Moorthy, Thomas N. Walsh, John Reynolds, Yuji Tachimori, Haruhiro Inoue, Hisahiro Matsubara, Shin-ichi Kosugi, Haiquan Chen, Simon Y. K. Law, C. S. Pramesh, Shailesh P. Puntambekar, Sudish Murthy, Philip Linden, Wayne L. Hofstetter, Madhan K. Kuppusamy, K. Robert Shen, Gail E. Darling, Flavio D. Sabino, Peter P. Grimminger, Sybren L. Meijer, Jacques J. G. H. M. Bergman, Maarten C. C. M. Hulshof, Hanneke W. M. van Laarhoven, Banafsche Mearadji, Roel J. Bennink, Jouke T. Annema, Marcel G. W. Dijkgraaf, Suzanne S. Gisbertz

BMC CANCER (2019)

Biographical-Item Gastroenterology & Hepatology

ISDE Presidential Biography: Enrique Moreno-Gonzalez, ISDE President [1995-1998]

M. Pera

DISEASES OF THE ESOPHAGUS (2019)

Article Surgery

Correlation of Gastric Volume and Weight Loss 5 Years Following Sleeve Gastrectomy

Clara Panella Vilamu, Marcos Busto, Alba Gonzalez, Carme Serra, Alberto Goday, Luis Grande, Manuel Pera, Jose M. Ramon

OBESITY SURGERY (2020)

Article Oncology

The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours

Maria Bencivenga, Elio Treppiedi, Mariagiulia Dal Cero, Lorena Torroni, Giuseppe Verlato, Mar Iglesias, Florence Renaud, Anna Tomezzoli, Claudia Castelli, Guillaume Piessen, Manuel Pera, Giovanni de Manzoni

JOURNAL OF SURGICAL ONCOLOGY (2020)

Article Surgery

Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years

Alberto Goday, Helena Julia, Aleix de Vargas-Machuca, Juan Pedro-Botet, Sergi Benavente, Jose M. Ramon, Manuel Pera, Anna Casajoana, Montserrat Villatoro, Laia Fontane, Maria Bisbe, Elisenda Climent, Olga Castaner, Juana A. Flores Le Roux, David Benaiges

Summary: The study showed that metabolic and bariatric surgery (MBS) had a positive effect on metabolically healthy patients with morbid obesity (MHMO), improving cardiometabolic and NAFLD markers significantly. Most metabolically unhealthy patients with morbid obesity (MUMO) who became healthy after 1 year remained healthy at 5 years after MBS.

SURGERY FOR OBESITY AND RELATED DISEASES (2021)

Review Surgery

State of the art of enhance recovery after surgery (ERAS) protocols in esophagogastric cancer surgery: the Western experience

Silvia Salvans, Luis Grande, Mariagiulia Dal Cero, Manuel Pera

Summary: Enhanced recovery after surgery (ERAS) programs provide a framework to standardize care processes and improve outcomes by reducing physiological surgical stress. Despite challenges in implementing ERAS in esophageal and gastric cancer resection procedures, systematic reviews have confirmed the benefits of reduced complications and hospital stay. However, there is heterogeneity and lack of standardization in the ERAS components. Despite the growing evidence of effectiveness, adherence to ERAS protocols remains low.

UPDATES IN SURGERY (2023)

Review Oncology

Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis

Mariagiulia Dal Cero, Maria Bencivenga, Drolaiz H. W. Liu, Michele Sacco, Mariella Alloggio, Kelly G. P. Kerckhoffs, Federica Filippini, Luca Saragoni, Mar Iglesias, Anna Tomezzoli, Fatima Carneiro, Heike I. Grabsch, Giuseppe Verlato, Lorena Torroni, Guillaume Piessen, Manuel Pera, Giovanni de Manzoni

Summary: The clinical behavior of signet ring cell histology in gastric cancer has been controversial due to the lack of a standardized definition. This meta-analysis aimed to gain a deeper understanding of the prognosis and clinicopathological features of signet ring cell gastric cancer compared to other histologies. The findings revealed that the prognosis of signet ring cell gastric cancer is closely linked to the disease stage and the specific comparison group employed. The lack of standardized classification may contribute to the variability in clinical behavior. Therefore, efforts should be made to establish a uniform classification system for gastric cancer to enhance clarity and coherence in research and clinical practice.

CANCERS (2023)

Article Health Care Sciences & Services

YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer

Maria Bencivenga, Lorena Torroni, Mariagiulia Dal Cero, Alberto Quinzii, Camilla Zecchetto, Valeria Merz, Simona Casalino, Francesco Taus, Silvia Pietrobono, Domenico Mangiameli, Federica Filippini, Mariella Alloggio, Claudia Castelli, Mar Iglesias, Manuel Pera, Davide Melisi

Summary: This study found that the activation of the YAP pathway is associated with poor prognosis in poorly cohesive gastric cancer, suggesting its important role in the development of this type of cancer.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Surgery

Development of the ParaOesophageal hernia SympTom (POST) tool

Aiysha Puri, Nikhil M. Patel, Viknesh Sounderajah, Lorenzo Ferri, Ewen A. Griffiths, Donald Low, Nick Maynard, Carmen Mueller, Manuel Pera, Mark I. van Berge Henegouwen, David Watson, Giovanni Zaninotto, George B. Hanna, Sheraz R. Markar

Summary: This study developed a symptom severity instrument (POST tool) specific to para-oesophageal hernia (POH). Through a systematic review and Delphi consensus process, the POST tool was created, which includes five symptoms that reached consensus among international experts.

BRITISH JOURNAL OF SURGERY (2022)

No Data Available